OP0284 Impact of a Nurse Led Program of Patient Self-Assessment of Disease Activity on the Management of Rheumatoid Arthritis: Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra)
Authors: M. Dougados, E. Perrodeau, F. Fayet, P. Gaudin, M.-H. Cerato, X. le Loet, R.-M. Flipo, L. Chabrefy, G. Mouterde, L. Euller-Ziegler, T. Schaeverbeke, B. Fautrel, A. Saraux, I. Valckaenaere, G. Chales, E. Dernis, P. Richette, X. Mariette, F. Berenbaum, J. Sibilia, P. Ravaud
Journal: Annals of the Rheumatic Diseases (2013)

<h3>Background</h3> The current T2T and EULAR recommendations (<i>e.g.</i> measures of disease activity must be obtained and documented regularly [1]. Nurses should promote self-management skills in order that patients might achieve a greater self efficacy and improvement [2]) are difficult to apply in daily practice <h3>Objectives</h3> To evaluate the impact of a nurse led program of patient self-assessment of disease activity on the management of Rheumatoid Arthritis (RA). <h3>Methods</h3> Study design: Prospective, randomized, controlled, open, 6-month trial (NCT #0131652)<b>.</b>Participants 1/<i>Patients</i>: Consecutive RA attending a clinic of the 20 participating centers were invited .2/ <i>Nurses</i> :all participated at a 1.5 day training session prior the start of the study. 3/<i>Treating rheumatologists</i>: aware of the study but not of its primary objective. Study treatment: a program including: 1) a video explaining both the interest, calculation and interpretation of the DAS28-ESR, 2) Training of a self joint assessment, 3) A booklet and a calculator permitting the patient to report the results of his/her “auto” DAS28-ESR and to show the results to his/her treating rheumatologist. Treatment allocation:After written informed consent, the treatment was allocated randomly via en electronic system (e.g. either this above program or an evaluation of potential co-morbidities (not reported here). Outcome variables:<i>Primary</i>: percentage of patients with a change in DMARD therapy during the 6 months follow-up period. <i>Other variables</i>: changes in symptomatic parameters. <h3>Results</h3> There was no difference in the baseline characteristics of the 970 recruited patients (488 and 482 in the active and control groups respectively): Age: 58±11 years, female gender: 79%, disease duration: 11[6.2-19.1] years, DAS28-ESR: 3.1±1.3, mHAQ: 0.25[0.00-0.62]; RAID: 2.7[1.3-4.3]. At the month 6 visit, the % patients bringing back a completed booklet was 89%. During the 6 months follow-up period, a DMARD therapy was changed in 17.2% <i>vs.</i> 10.9% in the active vs. control group (<i>p</i>=0.0012) (OR=1.70 [1.17-2.19]). During the time of the study, there was no statistically significant inter-group differences (-0.10 [-0.10;0.3], p=0.41; -0.03 [-0.25; 0.18], p=0.761; -0.01 [-0.05; 0.04], p=0.806, in the DAS28-ESR, HAQ and RAID in the active <i>vs</i>. control group respectively. <h3>Conclusions</h3> This study demonstrates the short term impact of a nurse leaded patient self assessment of RA disease activity program. Longer term follow up of patients is required to better evaluate the clinical benefit of this program <h3>References</h3> Smolen J.S. <i>et al</i>; Ann Rheum Dis 2010; 69, 631-7 Van Eijk-Hustings y. <i>et al</i>. Ann Rheum Dis. 2012; 71, 13-9 <h3>Acknowledgements</h3> This study was conducted thanks to a grant from the French National Research Program ( PHRC) and thanks to an unrestricted grant from Roche Ltd France <h3>Disclosure of Interest</h3> None Declared